Vanda Pharmaceuticals Inc (VNDA)
4.115
+0.22
(+5.78%)
USD |
NASDAQ |
Mar 28, 16:00
4.19
+0.08
(+1.82%)
After-Hours: 19:55
Vanda Pharmaceuticals Revenue (TTM): 192.64M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 192.64M |
September 30, 2023 | 211.85M |
June 30, 2023 | 238.35M |
March 31, 2023 | 256.69M |
December 31, 2022 | 254.38M |
September 30, 2022 | 257.92M |
June 30, 2022 | 262.70M |
March 31, 2022 | 266.20M |
December 31, 2021 | 268.68M |
September 30, 2021 | 268.32M |
June 30, 2021 | 258.53M |
March 31, 2021 | 252.84M |
December 31, 2020 | 248.17M |
September 30, 2020 | 241.44M |
June 30, 2020 | 240.62M |
March 31, 2020 | 237.48M |
December 31, 2019 | 227.19M |
September 30, 2019 | 219.30M |
June 30, 2019 | 208.95M |
March 31, 2019 | 197.24M |
December 31, 2018 | 193.12M |
September 30, 2018 | 184.35M |
June 30, 2018 | 176.55M |
March 31, 2018 | 171.26M |
December 31, 2017 | 165.08M |
Date | Value |
---|---|
September 30, 2017 | 159.05M |
June 30, 2017 | 156.20M |
March 31, 2017 | 150.17M |
December 31, 2016 | 146.02M |
September 30, 2016 | 139.62M |
June 30, 2016 | 129.48M |
March 31, 2016 | 121.04M |
December 31, 2015 | 109.92M |
September 30, 2015 | 93.44M |
June 30, 2015 | 79.88M |
March 31, 2015 | 63.16M |
December 31, 2014 | 50.16M |
September 30, 2014 | 43.57M |
June 30, 2014 | 37.50M |
March 31, 2014 | 34.95M |
December 31, 2013 | 33.88M |
September 30, 2013 | 33.02M |
June 30, 2013 | 32.60M |
March 31, 2013 | 32.65M |
December 31, 2012 | 32.73M |
September 30, 2012 | 33.18M |
June 30, 2012 | 32.86M |
March 31, 2012 | 31.91M |
December 31, 2011 | 31.27M |
September 30, 2011 | 30.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
192.64M
Minimum
Dec 2023
268.68M
Maximum
Dec 2021
240.47M
Average
244.81M
Median
Revenue (TTM) Benchmarks
ADMA Biologics Inc | 258.22M |
Johnson & Johnson | 93.02B |
Nektar Therapeutics | 90.12M |
Amicus Therapeutics Inc | 399.36M |
CASI Pharmaceuticals Inc | 42.26M |